Product Details
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2
infection
Clinical Use
Accurate rapid diagnostic tests for SARS-CoV-2 infection could
contribute to clinical and public health strategies to manage the
COVID-19 pandemic. Point-of-care antigen and molecular tests to
detect current infection could increase access to testing and early
confirmation of cases, and expediate clinical and public health
management decisions that may reduce transmission.
Main Components
Test Cassettes
Sample tubes
Extraction Buffer
Swabs
Tube stand
Instruction for use
Package specification
1T/Box,5T/Box
Product Feature
High accuracy, specificity and sensitivity
Detectino of mutations
Safety and Reliability
Simple operation, No extra instrument
Results in 15minutes and easy to read
Intend Use
This rapid test kit is designed to qualitatively detect the
SARS-CoV-2 virus nucleocapsid antigen from the nasal secretions of
individuals suspected of COVID-19.
Use Step
- Open the sealed pouch and remove the test casstette. Lay it face up
on a clean, dry and flat surface.
- Unpack the sample extraction, add all of the sample extraction into
the sample tube and then put the tube into tube stand.
- Gently, insert the entire absorbent tip of the swab (around 1.5 cm)
into your nostril. Rotate walls of your nostril 5 times or more.
Use the same swab to repeat steps in the other nostril.
- Insert the swab into the ssample tube with extraction buffer. Mix
well. Mix well and squeeze the swab 10-15 times by compressing the
walls of the tube against the swab. Roll the swab head against the
inner wall of the tubes as you remove it.
- Close the cape of the sample tube. Add 3 full drops of the mixed
solution vertically into the sample well(S) of the test cassette.
- Read the result 15-20minutes after adding the sample. Result got
after 20 minutes is invalid.
Result Interpretation
POSITIVE: Two colored bands appear on the membrane. One band appears in the
control region (C) and another band appears in the test region (T).
NEGATIVE: Only one colored band appears, in the control region (C). No apparent colored band appears in the test region (T).
INVALID: If there is no Control line (C) or only a Test line (T) in the result window, the test did not run correctly and the
results are not valid.
Virus Sources
Global high frequency mutation | Alpha / B.1.1.7(U.K.) | Beta I B.1.351(South Africa) |
Gemma I P.1(Brazil) | Kappa I B.1.617.1(India) | Delta I B.1.617.2(India) |
C.37,ect | Alpha I B.1.17(U.K.) | B.1.36.16.etc |
A.2.5,etc | A.23.1 | Alpha I B.1.17(U.K.) |
B.1.1.33.etc | C.1.1.etc. | |
Certificate (CE approved)
Company Profile
Labnovation Technologies, Inc. is an original manufacturer
established in Shenzhen, China since 2001. We are dedicated in
developing and manufacturing IVD instruments and reagents including
HbA1c analyzer and reagents, rapid test reader & reagents,
hematology reagents, clinical chemistry reagents, electrolyte
reagents, wash solution and urine test reagents.
Labnovation products are developed in house, tested extensively in
clinics and passed strict quality controls. All of our products are
CE marked and approved by SFDA. In the past 15 years, our products
have been exported to 110 different countries and used in 8000
hospitals worldwide. We provide both ready-to-use final products
and bulk OEM reagents, including ready-to-use reagents,
concentrated, and powder.
With an investment of 10% of our annual sales into R&D, we
release new products every years. We win more and more domestic and international cooperation by
company reputation and products quality while we actively take part
in fairs like MEDICA,AACC, ARBA HEALTH and so on through which we
are well-known by the companies in this field.